Are All Warfarin Preparations Alike? A Comprehensive Overview of Current Data, Emerging Opinions, and Perspectives Nancy Jane GiaQuinto OriginalPaper Pages: 139 - 144
Unfractionated Heparin Is the Heparin of Choice in the Management of Patients with Acute Coronary Syndromes Syed M. Jafri OriginalPaper Pages: 145 - 147
High Platelet Count in Platelet-Rich Plasma Reduces Measured Platelet Inhibition by Abciximab but not Tirofiban nor Eptifibatide Glycoprotein IIb/IIIa Receptor Antagonists Dean J. KereiakesThomas M. BroderickCharles A. Abbottsmith OriginalPaper Pages: 149 - 155
Antiplatelet Therapy in Interventional Cardiology: I. Newer Oral Antiplatelet Agents Fahim H. JafaryCarey D. Kimmelstiel OriginalPaper Pages: 157 - 162
Antiplatelet Therapy in Interventional Cardiology: II. Glycoprotein IIb/IIIa Inhibitors Fahim H. JafaryCarey D. Kimmelstiel OriginalPaper Pages: 163 - 174
A Practical Approach to the Diagnosis and Management of Thrombocytopenia Associated with Glycoprotein IIb/IIIa Receptor Inhibitors Joan LlevadotStephanie A. CoulterRobert P. Giugliano OriginalPaper Pages: 175 - 180